NEW DELHI--August 20, 2024--Researched by Industrial Info Resources (Sugar Land, Texas)--Monoclonal antibodies (mAbs) have transformed the medical sector by offering targeted treatment options for a wide range of diseases. Produced in laboratories, mAbs act like natural antibodies that can restore, enhance or mimic the immune system's ability to identify and neutralize specific antigens (which are proteins on the surface of cells). By precisely targeting these antigens, mAbs provide focused treatment for various illnesses.